Philips has scored a de novo clearance from the FDA for the first laser-based device for removing blood vessel filter implants that aim to strain out traveling blood clots before they damage the lungs or other organs. The CavaClear device is designed for use when other retrieval methods have failed, including times when a filter has become lodged in a blood vessel.
/PRNewswire/ Today, the U.S. Food and Drug Administration authorized marketing of the first laser-based device for the removal of Inferior Vena Cava (IVC).
The Philips CavaClear Laser Sheath device facilitates detachment of firmly adherent inferior vena cava filters from the IVC wall using ultraviolet laser energy to remove a small amount of the tissue.